Literature DB >> 10856714

Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly.

D A Gordon1, H Jamil.   

Abstract

The microsomal triglyceride transfer protein (MTP) is necessary for the proper assembly of the apolipoprotein B containing lipoproteins, very low density lipoprotein and chylomicrons. Recent research has significantly advanced our understanding of the role of MTP in these pathways at the molecular and cellular level. Biochemical studies suggest that initiation of lipidation of the nascent apolipoprotein B polypeptide may occur through a direct association with MTP. This early lipidation may be required to allow the nascent polypeptide to fold properly and therefore avoid ubiquitination and degradation. Concerning the addition of core neutral lipids in the later stages of lipoprotein assembly, cell culture studies show that MTP lipid transfer activity is not required for this to occur for apolipoprotein B-100 containing lipoproteins. Likewise, MTP does not appear to directly mediate addition of core neutral lipid to nascent apoB-48 particles. However, new data indicate that MTP is required to produce triglyceride rich droplets in the smooth endoplasmic reticulum which may supply the core lipids for conversion of nascent, dense apoB-48 particles to mature VLDL. In addition, assembly of dense apolipoprotein B-48 containing lipoproteins has been observed in mouse liver in the absence of MTP. As a result of these new data, an updated model for the role of MTP in lipoprotein assembly is proposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856714     DOI: 10.1016/s1388-1981(00)00049-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: the case of the MTP gene.

Authors:  Derek M Huffman; Joris Deelen; Kenny Ye; Aviv Bergman; Eline P Slagboom; Nir Barzilai; Gil Atzmon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-10       Impact factor: 6.053

2.  Adaptation of enterocytic Caco-2 cells to glucose modulates triacylglycerol-rich lipoprotein secretion through triacylglycerol targeting into the endoplasmic reticulum lumen.

Authors:  Thomas Pauquai; Julien Bouchoux; Danielle Chateau; Romain Vidal; Monique Rousset; Jean Chambaz; Sylvie Demignot
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 3.  Hepatic regulation of apolipoprotein B.

Authors:  Rita Kohen Avramoglu; Khosrow Adeli
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

4.  Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.

Authors:  Erica Allen; Klaus B Piontek; Elizabeth Garrett-Mayer; Miguel Garcia-Gonzalez; Kerry Lee Gorelick; Gregory G Germino
Journal:  Hum Mol Genet       Date:  2005-11-21       Impact factor: 6.150

Review 5.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

6.  Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats.

Authors:  Gemma Sangüesa; Sonali Shaligram; Farjana Akther; Núria Roglans; Juan C Laguna; Roshanak Rahimian; Marta Alegret
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

Review 7.  Genotype 3 Infection: The Last Stand of Hepatitis C Virus.

Authors:  Austin Chan; Keyur Patel; Susanna Naggie
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

Review 8.  Beyond statins: new lipid lowering strategies to reduce cardiovascular risk.

Authors:  Davide Noto; Angelo B Cefalù; Maurizio R Averna
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

9.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

10.  Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.

Authors:  Emma M Allister; Erin E Mulvihill; P Hugh R Barrett; Jane Y Edwards; Lindsey P Carter; Murray W Huff
Journal:  J Lipid Res       Date:  2008-06-27       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.